Plaintiffs allege that Novo Nordisks marketing campaign misled consumers by focusing on the benefits of weight loss while downplaying the potential for severe health risks, including intestinal blockages and stomach paralysis
However you armor up or tap out, whether it is work, food, alcohol, etc
Daver NG, Garcia JS, Jonas BA, Kelly KR, Assouline S, Brandwein JM, Fenaux P, Olin RL, Martinelli G, Paolini S, Pigneux A, Pollyea DA, Powell BL, Roboz GJ, Tafuri A, Vey N, Visani G, Yee KWL, Dail M, Green C, Kirschbrown WP, W-J H, Ott MG, Onishi M, Wang J, Konopleva MY, and Andreeff M
Patients with diabetic retinopathy should have appropriate eye evaluations when initiating or intensifying semaglutide therapy, as rapid improvement in glucose control may temporarily worsen retinopathy
GLP-1s also work on the satiety centers of the brain and counteract the effects of ghrelin, the hormone that makes you feel hungry
For most of these substances, the reduction in risk was in the 15% to 20% range